WASHINGTON, Feb. 14,
2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE:
EVH), a company that specializes in better health outcomes for
people with complex conditions through proven solutions that make
health care simpler and more affordable, today appointed
Russell Glass to its Board of
Directors. Glass has almost 25 years of experience as a successful
technology and health care executive who currently serves as Chief
Executive Officer of Headspace, a pioneering company focused on
digitally enabled mental health support for employers, health plans
and consumers.
Glass will fill the seat vacated by Dr. Tunde Sotunde, who
retired from the Board effective February
12, 2024. Dr. Sotunde stated, "I've been incredibly
impressed with Evolent during my time on the Board. I am confident
in the significant opportunity that lies ahead for the company. I
believe Evolent remains well positioned to continue its innovative
leadership in the value-based specialty care market."
Seth Blackley, Chief Executive
Officer and Co-founder of Evolent, stated, "I want to thank Tunde
for his many contributions to the Board over the last several
years. I would also like to take this opportunity to welcome
Russ Glass to the Evolent Board of
Directors. Russ brings incredible experience at the intersection of
health care services, technology and artificial intelligence at a
pivotal time in Evolent's history."
Glass added, "Like Headspace, Evolent is tackling two of the
largest challenges in health care today – improving patient
experiences to drive positive health outcomes and increasing
affordability and access for all. I am excited to work closely with
the Evolent team and Board to support the exciting evolution and
growth in Evolent's value-based specialty care platform."
Chair of the Evolent Board of Directors Cheryl Scott added, "On behalf of my fellow
Directors, we want to thank Tunde for his commitment and valuable
contributions to Evolent during the last several years." Ms. Scott
continued, "After conducting a broad, national search, the Board is
pleased to appoint Russell Glass as
an Evolent Director. Russ adds critical depth in health care
technology innovation as well as an important perspective on how
complex care and mental health interact. In addition, Russ
compliments the deep health care and finance expertise resident on
the existing Evolent Board, including with our four senior health
plan executives."
Glass has served as CEO of Headspace since 2021. Prior to that,
he held multiple CEO roles, most recently at Ginger, an on-demand
mental health platform that merged with Headspace in 2022,
resulting in the creation of an end-to-end digital mental health
platform. In addition, Russ founded and served as the CEO and
President of Bizo, a B2B marketing and data platform, which he sold
to LinkedIn in 2014. Following the sale of Bizo, Russ became a
Product Vice President at LinkedIn, where he delivered
industry-leading solutions to help marketers get to the right
professionals while improving the online experience of LinkedIn
members. He holds a Bachelor of Science in Engineering and
Economics from Duke University.
About Evolent Health
Evolent (NYSE: EVH) specializes in better health outcomes for
people with complex conditions through proven solutions that make
health care simpler and more affordable. Evolent serves a national
base of leading payers and providers and is consistently recognized
as a top place to work in health care nationally. Learn more about
how Evolent is changing the way health care is delivered by
visiting evolent.com.
Contacts
Seth R. Frank
Vice President, Investor Relations
Evolent
sfrank@evolent.com
571.895.3919 (W)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/evolent-adds-russell-glass-headspace-ceo-to-board-of-directors-302062295.html
SOURCE Evolent Health